Traphaco and its partners received commemorative medals from the Organizing Committee . Within the framework of the conference, Traphaco was proud to be one of the partners and actively contributed through the specialized report "Effects of Ursodeoxycholic Acid in the treatment of gallstones and cholestatic liver disease" presented by the company's leading experts. The report highlighted the outstanding mechanisms of action of ursodeoxycholic acid, including the ability to dissolve gallstones and improve liver function, especially in patients with primary biliary cholangitis and cholesterol gallstones. Thereby, this solution helps reduce the size of gallstones, prevent the risk of surgical intervention, and reduce clinical symptoms such as itching, jaundice and fatigue.
Pharmacist Duong Quynh Anh, representing Traphaco, reported on the topic "Effects of Ursodeoxycholic Acid in the treatment of gallstones and cholestatic liver disease". In addition to sharing
scientific knowledge, Traphaco also introduced the product Ursodeoxycholic Acid, which was transferred technology from Daewoong Pharmaceutical Group, Korea. The product not only brings outstanding treatment results but is also part of the technology transfer project of high-quality pharmaceutical products between Traphaco and Daewoong. With this project, Traphaco has been and is continuing to bring to the market advanced products with global quality standards, providing optimal treatment options for patients. The event marked an important step forward for Traphaco in fulfilling its commitment to continuously improve and enhance the quality of treatment for Vietnamese patients, while affirming the company's position in the pharmaceutical field, especially in the group of liver and bile products and technology-transferred pharmaceutical products.
Booth introducing Traphaco's treatment solutions for hepatobiliary and pancreatic diseases https://traphaco.com.vn/traphaco-dong-hanh-tai-hoi-nghi-gan-mat-tuy-viet-nam-2024
Comment (0)